MYOS Issues Special Letter to Shareholders: Company Committed to R&D, Developing Innovative Products and Formulations
August 06, 2012 07:55 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwire - Aug 6, 2012) - MYOS Corporation's (OTCBB: MYOS) Board of Directors today issued the following Letter to Shareholders:
Dear Shareholder:
Your MYOS...
MYOS Announces $5.6 Million Equity Private Placement
July 02, 2012 08:59 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwire - Jul 2, 2012) - MYOS Corporation (OTCBB: MYOS) (the "Company") today announced that it has entered into agreements with various institutions, accredited investors and...
MYOS Names Veteran Biotechnology Executive Dr. Sol J. Barer to Chair Scientific Advisory Board
June 27, 2012 07:55 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwire - Jun 27, 2012) - MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of muscle health and performance therapeutic...
MYOS Appoints Astronaut Buzz Aldrin to Its Board of Directors
May 31, 2012 08:25 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwire - May 31, 2012) - MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of muscle health and performance therapeutic...
MYOS Signs Distribution Deal, Sees Year One Sales Exceeding $5 Million
May 22, 2012 08:29 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwire - May 22, 2012) - MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of muscle health and performance therapeutic...
Atlas Therapeutics Changes Its Name and Ticker Symbol to MYOS Corporation and "MYOS"; Launches New Corporate Website
May 21, 2012 06:55 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwire - May 21, 2012) - Atlas Therapeutics Corporation (OTCBB: ATTH) (OTCBB: MYOS), a company focused on the discovery, development and commercialization of muscle health...